Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State
Clinical trial NCT01930006 · COMPLETED
Trial details
- NCT number
- NCT01930006
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.